Comments on: CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study

Affiliations

¹ The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), No. 54 Post Road, Shangcheng District, Hangzhou, 310000, Zhejiang, China.
² Department of Intensive Care Unit, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, No. 54 Post Road, Shangcheng District, Hangzhou, 310000, Zhejiang Province, China.
³ Department of Intensive Care Unit, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, No. 54 Post Road, Shangcheng District, Hangzhou, 310000, Zhejiang Province, China. weiyidiandian@zcmu.edu.cn.

^# Contributed equally.

Comment

Meng-Yuan Shen et al. Hepatol Int. 2025 Dec.

. 2025 Dec;19(6):1505-1506.

doi: 10.1007/s12072-025-10909-0. Epub 2025 Sep 17.

¹ The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), No. 54 Post Road, Shangcheng District, Hangzhou, 310000, Zhejiang, China.
² Department of Intensive Care Unit, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, No. 54 Post Road, Shangcheng District, Hangzhou, 310000, Zhejiang Province, China.
³ Department of Intensive Care Unit, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, No. 54 Post Road, Shangcheng District, Hangzhou, 310000, Zhejiang Province, China. weiyidiandian@zcmu.edu.cn.

^# Contributed equally.

No abstract available

Conflict of interest statement

Declarations. Conflict of interest: The authors have no conflicts to report. Ethical approval: There are no ethical issues.

CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study.
Liu Z, Li X, Huang Y, Chang X, Zhang H, Wu X, Diao Y, He F, Sun J, Feng B, Liang H. Liu Z, et al. Hepatol Int. 2025 Dec;19(6):1397-1411. doi: 10.1007/s12072-025-10877-5. Epub 2025 Jul 23. Hepatol Int. 2025. PMID: 40702274

1. Liu Z, Li X, Huang Y, Chang X, Zhang H, Wu X, et al. CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study. Hepatol Int. 2025. https://doi.org/10.1007/s12072-025-10877-5 - DOI - PubMed
1. Lin YM, Paolucci I, O’Connor CS, et al. Ablative margins of colorectal liver metastases using deformable CT image registration and autosegmentation. Radiology. 2023;307(2): e221373 - DOI - PubMed
1. Mrouj K, Andrés-Sánchez N, Dubra G, et al. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proc Natl Acad Sci U S A. 2021;118(10): e2026507118 - DOI - PubMed - PMC
1. Wang Y, Chi S, Tian Y, et al. Construction of an artificially intelligent model for accurate detection of HCC by integrating clinical, radiological, and peripheral immunological features. Int J Surg. 2025;111(4):2942–2952 - DOI - PubMed - PMC
1. Shi Y, Wang M, Liu H, Zhao F, Li A, Chen X. MIF: Multi-shot interactive fusion model for cancer survival prediction using pathological image and genomic data. IEEE J Biomed Health Inform. 2025;29(5):3247–3258 - DOI - PubMed